Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.20
+8.42 (65.88%)
At close: Mar 6, 2026, 4:00 PM EST
21.16
-0.04 (-0.19%)
After-hours: Mar 6, 2026, 7:58 PM EST
DAWN Market Cap
DAWN has a market cap or net worth of $2.19 billion as of March 6, 2026. Its market cap has increased by 84.34% in one year.
Market Cap
2.19B
Enterprise Value
1.75B
1-Year Change
84.34%
Ranking
Category
Stock Price
$21.20
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has increased from $965.40M to $2.19B, an increase of 126.84%. That is a compound annual growth rate of 18.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.32B | 37.96% |
| Dec 31, 2025 | 956.94M | -25.11% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.35B |
| Adaptive Biotechnologies | 2.29B |
| Ocular Therapeutix | 2.22B |
| Zai Lab | 2.20B |
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Mineralys Therapeutics | 2.11B |